Expert Perspectives on Checkpoint Inhibitors in Gastric Cancer 

Session Chair(s)

• 

  Florian Lordick, MD, PhD

  Leipzig University Medical Center
  Leipzig, Germany

Supported by Novartis

Presentations:

• 13:30 – 13:35

  Welcome and Program Overview
  

  Session Chair: Florian Lordick, MD, PhD – Leipzig University Medical Center
• 13:35 – 13:50

  Disease Overview and Current Management
  

  Session Speaker: Maria Alsina
• 13:50 – 14:05

  Panel Discussion 1: Current Unmet Needs in the Diagnosis and Management of Metastatic G/GEJ Adenocarcinoma
  

  Session Moderator: Florian Lordick, MD, PhD – Leipzig University Medical Center

  Session Speaker: Maria Alsina
• 14:05 – 14:20

  1L Treatment of G/GEJ Adenocarcinoma
  

  Session Speaker: Florian Lordick, MD, PhD – Leipzig University Medical Center
• 14:20 – 14:35

  Panel Discussion 2: Evolution of Treatments and Role of Checkpoint Inhibitors in Locally Advanced, Unresectable or Metastatic G/GEJ Adenocarcinoma
  

  Session Chair: Florian Lordick, MD, PhD – Leipzig University Medical Center
• 14:35 – 15:00

  Q&A Session
  

  Session Moderator: Florian Lordick, MD, PhD – Leipzig University Medical Center

  Session Speaker: Maria Alsina